Technical Analysis for IVA - Inventiva S.A.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Down |
Historical IVA trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.69% | |
Narrow Range Bar | Range Contraction | 0.69% | |
Outside Day | Range Expansion | 0.69% | |
Oversold Stochastic | Weakness | 0.69% | |
Narrow Range Bar | Range Contraction | -0.38% | |
NR7 | Range Contraction | -0.38% | |
Inside Day | Range Contraction | -0.38% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Rose Above Previous Day's High | 4 days ago |
Outside Day | 4 days ago |
Up 2% | 4 days ago |
Up 1% | 4 days ago |
Fell Below Previous Day's Low | 4 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Steatohepatitis Hepatitis Non Alcoholic Fatty Liver Disease Transcription Fibrosis Related Disease Related Diseases Transcription Factors DNA Small Molecule Therapies Transcription Factor Epigenetics Hepatitis A Receptor
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Steatohepatitis Hepatitis Non Alcoholic Fatty Liver Disease Transcription Fibrosis Related Disease Related Diseases Transcription Factors DNA Small Molecule Therapies Transcription Factor Epigenetics Hepatitis A Receptor
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.14 |
52 Week Low | 9.01 |
Average Volume | 32,992 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 14.47 |
20-Day Moving Average | 14.11 |
10-Day Moving Average | 13.63 |
Average True Range | 0.63 |
ADX | 24.85 |
+DI | 25.76 |
-DI | 17.80 |
Chandelier Exit (Long, 3 ATRs ) | 13.62 |
Chandelier Exit (Short, 3 ATRs ) | 14.23 |
Upper Bollinger Band | 15.38 |
Lower Bollinger Band | 12.83 |
Percent B (%b) | 0.15 |
BandWidth | 18.05 |
MACD Line | -0.30 |
MACD Signal Line | -0.19 |
MACD Histogram | -0.1073 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 13.63 | ||||
Resistance 3 (R3) | 13.67 | 13.58 | 13.56 | ||
Resistance 2 (R2) | 13.58 | 13.48 | 13.56 | 13.53 | |
Resistance 1 (R1) | 13.40 | 13.41 | 13.36 | 13.36 | 13.51 |
Pivot Point | 13.31 | 13.31 | 13.29 | 13.29 | 13.31 |
Support 1 (S1) | 13.13 | 13.21 | 13.09 | 13.09 | 12.93 |
Support 2 (S2) | 13.04 | 13.14 | 13.02 | 12.91 | |
Support 3 (S3) | 12.86 | 13.04 | 12.88 | ||
Support 4 (S4) | 12.82 |